Stephanie Cape, PhD

Office Location:

Dr. Stephanie Cape heads the research and development and delivery teams within scientific affairs at Labcorp Drug Development. The scientific affairs team is focused on ensuring that Labcorp is positioned with the right technologies and expertise to effectively support the rapidly evolving needs of pharmaceutical testing. In this role, Stephanie concentrates on advancing laboratory technologies to enable new capabilities in characterization, clinical chemistry, biomarkers and bioanalysis.

Over the past 12 years with Labcorp Drug Development, Stephanie has served in a variety of scientific leadership roles, been actively engaged in a number of industry groups and grown a particular interest in enabling new technologies. Recently, she has served in a number of leadership positions within the American Association of Pharmaceutical Scientists (AAPS) organization, including as a member of the Scientific Advisory Committee; co-chair of the Bioanalytical Community; chair for the Land O’ Lakes conference; and chair of the Mass Spectrometry Focus Group. She also participates in the Bioanalysis Zone and Bioanalysis Journal as a subject matter expert. Stephanie has a particular passion for patient-centric sampling and has found a community of like-minded colleagues through the Global Patient Centric Sampling Interest Group and AAPS Microsampling and Patient Centric Sampling team where she is an active contributor.

Stephanie has authored over 30 peer-reviewed publications, including four book chapters, and has contributed to numerous posters and presentations.

She received her BS in chemistry from the University of Illinois Urbana-Champaign in 2003 and her PhD in analytical chemistry from the University of Wisconsin-Madison in 2007.